| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/09/2011 | WO2011109246A1 Antibody specific for apolipoprotein and methods of use thereof |
| 09/09/2011 | WO2011109108A1 Monoclonal antibodies directed to cd20 |
| 09/09/2011 | WO2011108714A1 Antibody constant region variant |
| 09/09/2011 | WO2011108626A1 Gastric cancer marker, and method for detecting gastric cancer |
| 09/09/2011 | WO2011108502A1 Modified antibody composition |
| 09/09/2011 | WO2011107989A1 Improved therapeutic antibodies against flagellated pseudomonas aeruginosa |
| 09/09/2011 | WO2011107957A1 Anti-her2 antibodies and compositions |
| 09/09/2011 | WO2011107586A1 Smoc1, tenascin-c and brain cancers |
| 09/09/2011 | WO2011107553A1 Antibodies against human csf-1r and uses thereof |
| 09/09/2011 | WO2011107544A1 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 09/09/2011 | WO2011107520A1 Expression of monoclonal antibodies in ciliate host cells |
| 09/09/2011 | WO2011107507A1 Biparatopic abeta binding polypeptides |
| 09/09/2011 | WO2011107480A1 Antigen binding proteins specific for serum amyloid p component |
| 09/09/2011 | WO2011107456A1 Novel protein with structural homology to proteins with il-8-like chemokine fold and uses thereof |
| 09/09/2011 | WO2011107291A1 Antibodies against phosphorylcholine in combination therapy with biologic agents |
| 09/09/2011 | WO2011106885A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | WO2011106882A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 09/09/2011 | WO2011085103A3 Plasma kallikrein binding proteins |
| 09/09/2011 | WO2011083091A3 Methods for treating pancreatic cancer |
| 09/09/2011 | WO2011079308A3 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof |
| 09/09/2011 | WO2011060206A3 Material and methods for treating or preventing her-3 associated diseases |
| 09/09/2011 | WO2011053565A3 Compositions and methods for detecting a tauopathy |
| 09/09/2011 | WO2011050152A3 Site-specific modification of proteins |
| 09/09/2011 | CA2828131A1 Expression of monoclonal antibodies in ciliate host cells |
| 09/09/2011 | CA2791962A1 Methods and compositions for treating degos' disease |
| 09/09/2011 | CA2791850A1 Molecular clone of hiv-1 |
| 09/09/2011 | CA2791676A1 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 09/09/2011 | CA2791671A1 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 09/09/2011 | CA2791658A1 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 09/09/2011 | CA2791652A1 Modified antibody composition |
| 09/09/2011 | CA2791648A1 Antibody specific for apolipoprotein and methods of use thereof |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791560A1 Monoclonal antibodies directed to cd20 |
| 09/09/2011 | CA2791538A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | CA2791409A1 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 09/09/2011 | CA2791383A1 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 09/09/2011 | CA2789557A1 Antigen binding proteins specific for serum amyloid p component |
| 09/09/2011 | CA2789076A1 Antibodies against human csf-1r and uses thereof |
| 09/09/2011 | CA2788289A1 Methods for screening antibodies |
| 09/09/2011 | CA2788275A1 Biparatopic abeta binding polypeptides |
| 09/08/2011 | US20110219464 Lung disease targets and uses thereof |
| 09/08/2011 | US20110218379 Epitopes derived from satb2 and uses thereof |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/08/2011 | US20110218329 Anti-il-6 antibodies, compositions, methods and uses |
| 09/08/2011 | US20110218328 Treatment and prophylaxis of amyloidosis |
| 09/08/2011 | US20110218327 METHOD FOR PROVIDING A β-LACTOGLOBULIN PRODUCT AND AN a-ENRICHED WHEY PROTEIN ISOLATE |
| 09/08/2011 | US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function |
| 09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
| 09/08/2011 | US20110218122 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 09/08/2011 | US20110217790 Novel CD3 Epsilon Immunogens And Antibodies |
| 09/08/2011 | US20110217366 Immunopotentiating composition |
| 09/08/2011 | US20110217321 Antibody drug conjugates (adc) that bind to 161p2f10b proteins |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217319 Methods of use of sialoadhesin factor-2 antibodies |
| 09/08/2011 | US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 09/08/2011 | US20110217317 Treatment of thrombocytopenia |
| 09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
| 09/08/2011 | US20110217307 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
| 09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
| 09/08/2011 | US20110217305 Anti-her2 antibodies and compositions |
| 09/08/2011 | US20110217304 Monoclonal antibodies directed to cd52 |
| 09/08/2011 | US20110217302 TCR Complex Immunotherapeutics |
| 09/08/2011 | US20110217298 Monoclonal antibodies directed to cd20 |
| 09/08/2011 | US20110217292 Monoclonal antibodies against hmgb1 |
| 09/08/2011 | US20110217291 Soluble hybrid fct receptors and related methods |
| 09/08/2011 | US20110217290 Treatment and/or prevention of peanut induced anaphylaxis |
| 09/08/2011 | US20110217287 Therapeutic composition comprising a botulinum neurotoxin |
| 09/08/2011 | US20110217237 Therapeutic dll4 binding proteins |
| 09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
| 09/08/2011 | US20110217231 Anti-tenascin monoclonal antibody therapy for lymphoma |
| 09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/07/2011 | EP2363486A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 09/07/2011 | EP2363484A2 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 09/07/2011 | EP2363471A1 Immunoassay method for human cxcl1 protein |
| 09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
| 09/07/2011 | EP2363418A2 Method of obtaining recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media |
| 09/07/2011 | EP2363417A1 Antibodies against insulin-like growth factor I receptor and uses thereof |
| 09/07/2011 | EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody |
| 09/07/2011 | EP2363415A2 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 09/07/2011 | EP2363410A1 Isoforms of MUC1 |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 09/07/2011 | EP2363146A1 Method for inhibiting metastasis in a stem cell fusion model of carcinogenesis |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2362945A1 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker |
| 09/07/2011 | EP2362911A1 An expression vector and processes thereof |
| 09/07/2011 | EP2362908A1 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/07/2011 | EP2362881A2 Crhr2 peptide agonists and uses thereof |
| 09/07/2011 | EP2362783A2 Light targeting molecules and uses thereof |
| 09/07/2011 | EP1996625B1 Anti-tat226 antibodies and immunoconjugates |
| 09/07/2011 | EP1877443B1 Monoclonal anti minichomosome maintenance 2 protein antibodies and methods for their use in the detection of cervical disease |
| 09/07/2011 | CN1903878B Anti SARS virus human source nature antibody IgG Fab section |
| 09/07/2011 | CN1886158B Pharmaceutical preparation comprising an antibody against the EGF receptor |
| 09/07/2011 | CN1761403B Method and compositions for improving animal health |
| 09/07/2011 | CN1526072B Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/07/2011 | CN102177179A Treatment of autoimmune and inflammatory disease |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102177177A Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1) |
| 09/07/2011 | CN102175858A Chemiluminescent immunity imaging detection method of EV71 (Enterovirus) virus |